share_log

BioNTech | 6-K: Pfizer and BioNtech Provide Update on mRNA-Based Combination Vaccine Program Against Influenza and Covid-19 in Individuals 18-64 Years of Age

BioNTech | 6-K: Pfizer and BioNtech Provide Update on mRNA-Based Combination Vaccine Program Against Influenza and Covid-19 in Individuals 18-64 Years of Age

BioNTech | 6-K:辉瑞和 BioNTech 提供基于 mRNA 的针对 18-64 岁人群的流感和 COVID-19 联合疫苗计划的最新情况
美股SEC公告 ·  08/16 06:58
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息